Pharmaceuticals

Business·Market Analysis·News·Pharmaceuticals

Formycon’s Dramatic Turn: From Breakthrough to Market Uncertainty

Formycon halts a Phase III trial for biosimilar FYB206 after encouraging U.S. FDA feedback, highlighting a strategic pivot to save costs. The decision is expected to yield significant double-digit million Euro savings, aligning science with fiscal prudence. Despite this, not all is

17 February 2025

Chemistry·Evolution·Healthcare·Innovations·Medicine·News·Pharmaceuticals

Revolutionary Drug Technique Could Slash Costs and Speed Up Treatments

Prof. Indrajeet Sharma and his team at the University of Oklahoma are introducing skeletal editing to modify drug molecules for enhanced therapies. The technique involves inserting nitrogen into existing medications, potentially accelerating development and reducing costs. Skeletal editing aims to create personalized

9 February 2025

Biotechnology·Evolution·Genetics·News·Pharmaceuticals·Science·Technology

Revolutionary DNA Technique Could Unravel Drug Trade Secrets

A study from Flinders University explores DNA analysis to link individuals to illicit drug production and transportation. Significant DNA transfer occurs between drug capsules and the ziplock bags used for transportation, even with brief contact. Capsule makers leave substantial DNA traces, while

3 February 2025